Brain entropy and neurotrophic molecular markers accompanying clinical improvement after ketamine: Preliminary evidence in adolescents with treatment-resistant depression.
Abhrajeet V RoyMichelle ThaiBonnie Klimes-DouganMindy Westlund SchreinerBryon A MuellerChristina Sophia AlbottKelvin O LimMark FiecasSusannah J TyeKathryn R CullenPublished in: Journal of psychopharmacology (Oxford, England) (2020)
Ketamine in adolescents with treatment-resistant depressionURL: https://clinicaltrials.gov/ct2/show/NCT02078817Registration number: NCT02078817.